PrecisionLife at Abu Dhabi Global Health Week 2025

Championing Longevity & Precision Medicine on the Global Stage

Steve Gardner, CEO of PrecisionLife, and Rowan Gardner, our Chief Business and Investment Officer, will be attending Abu Dhabi Global Health Week 2025 (15–17 April), joining a prestigious gathering of global health visionaries, policy leaders and innovators.

This year’s Forum @ ADGHW, hosted by the Department of Health – Abu Dhabi, centres around transformative themes that reflect our mission: precision medicine and longevity in complex diseases, women’s health, and more personalized and equitable healthcare.

Leading the Charge in Precision Medicine and Longevity

As an internationally recognized authority on precision medicine and understanding complex disease biology, Steve Gardner brings over 30 years of experience advancing healthcare through computational innovation. His vision for proactive, data-driven approaches to increase healthspan is already reshaping chronic disease care—delivering better diagnostic tools, more targeted treatments, and accurate prediction and prevention of disease—to reduce the cost of care and improving outcomes for patients around the world.

Driving Women's Health Innovation

Rowan Gardner is an influential voice in precision medicine, closing the gender data gap in healthcare, particularly through her work on projects such as TRANSCEND—an award-winning international initiative transforming how we detect, diagnose and treat endometriosis and other chronic conditions affecting millions of women.

At Global Health Week, Rowan will advocate for the need to personalize medicine for complex diseases affecting women's health, integrate diverse health data into research pipelines, and catalyse investments into solutions that deliver equity and real-world impact.

Building a Global Future of Predictive and Personalized Health

As the Middle East cements its position as a hub for innovation and healthcare excellence, Abu Dhabi Global Health Week offers a powerful platform to build partnerships, accelerate translational science, and deliver on the promise of predictive, preventive and personalised medicine.

We look forward to engaging with fellow leaders and collaborators as we pave the way towards better health and longevity.

PrecisionLife is a clinical-stage precision medicine company creating better diagnostic tools and more personalized treatment options to predict, treat, and prevent complex chronic diseases, which account for over 80% of healthcare spending. Their growing prevalence is making healthcare increasingly unaffordable in all major economies.

The AI and combinatorial analytics PrecisionLife platform is unparalleled in its ability to understand disease biology – identifying the specific causes of disease and biomarkers to stratify patients by molecular mechanism for the first time in many complex conditions. This enables us to accurately link individuals to the drug targets, clinical trials and treatments that will benefit them – leading to earlier, more accurate and effective disease prediction, diagnosis, treatment, and prevention.

Our unique disease insights, precision medicine tests, and programs hold the key to increasing the rate of success in drug development, reducing the global burden of chronic diseases, and improving health and longevity for billions of people.

Let’s meet in Abu Dhabi

If you’re attending ADGHW and would like to connect with Steve and Rowan, please get in touch.